We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TEAD:NASDAQTeads Holding Co. Analysis

Data as of 2026-05-26 - not real-time

$1.13

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Teads Holding Co. is trading at $1.13, comfortably above its 20‑day ($1.01) and 50‑day ($0.82) simple moving averages and just shy of the 200‑day average ($1.04), indicating a short‑term bullish bias. The 14‑day RSI sits at 60.7, suggesting continued upward momentum without being overbought, while the MACD line remains above its signal line, reinforcing the bullish technical picture. However, the fundamentals are markedly weak: revenue fell 7.1% year‑over‑year, operating margins are negative (-7.1%), and the company posted a net loss of $5.39 per share, with a forward EPS of –$0.55. Financial health is strained, evidenced by a debt‑to‑equity ratio of over 1,300, a cash balance of $98.6 M versus $653 M of debt, and a max drawdown of –81% over recent periods. Volatility is extreme at 144% over the past 30 days and beta is high (computed 3.42), making the stock highly sensitive to market swings. The market sentiment gauge is in “Extreme Greed” territory (90.75), but the decreasing volume trend and thin liquidity raise concerns about price stability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish technical indicators (price above SMAs, bullish MACD)
  • Extreme Greed sentiment indicating short‑term buying pressure
  • Decreasing volume and high volatility signal caution

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Negative earnings, margins and cash burn
  • Excessive leverage with debt‑to‑equity > 1,300
  • High beta and volatility exposing investors to market risk

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Low price‑to‑book and price‑to‑sales ratios suggest some floor value
  • Potential restructuring or strategic pivot could improve cash position
  • Persistent financial distress and regulatory headwinds limit upside

Key Metrics & Analysis

Financial Health

Revenue Growth-7.10%
Profit Margin-39.14%
P/E Ratio-2.1
ROE-190.89%
ROA-1.28%
Debt/Equity1300.15
P/B Ratio1.1
Op. Cash Flow$-26299000
Free Cash Flow$-10316250
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI60.7
Support$0.80
Resistance$1.39
MA 20$1.01
MA 50$0.82
MA 200$1.04
MACDBullish
VolumeDecreasing
Fear & Greed Index90.75

Valuation

Target Price$1.00
Upside/Downside-11.72%
GradeOvervalued
TypeValue

Risk Assessment

Beta3.42
Volatility144.28%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.